Xavier Charmetant

Xavier Charmetant

INSERM - Paris / France
Others
AD Scientific Index ID: 4583224
person_outline Xavier Charmetant's MOST POPULAR ARTICLES
1-) A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysisM Espi, X Charmetant, T Barba, C Mathieu, C Pelletier, L Koppe, ...Kidney international 101 (2), 390-402, 2022562022
2-) The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysisM Espi, X Charmetant, T Barba, L Koppe, C Pelletier, E Kalbacher, ...Kidney international 100 (4), 928-936, 2021562021
3-) Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipientsX Charmetant, M Espi, I Benotmane, V Barateau, F Heibel, F Buron, ...Science Translational Medicine 14 (636), eabl6141, 2022532022
4-) SARS‐CoV‐2‐specific serological and functional T cell immune responses during acute and early COVID‐19 convalescence in solid organ transplant patientsA Favà, L Donadeu, N Sabé, V Pernin, J González‐Costello, L Lladó, ...American Journal of Transplantation 21 (8), 2749-2761, 2021642021
5-) A new expression of immune checkpoint inhibitors’ renal toxicity: when distal tubular acidosis precedes creatinine elevationX Charmetant, C Teuma, J Lake, F Dijoud, V Frochot, A DeebClinical kidney journal 13 (1), 42-45, 2020332020